TRICUSPID VALVE REGURGITATION IN PATIENTS UNDERGOING ENDOCARDIAL LEADS PLACEMENT

Objective: To assess prospectively the presence and degree of tricuspid regurgitation (TR) after right ventricular (RV) lead placement utilizing 2-dimensional and doppler echocardiography in a group of patients implanted with Permanent pace-maker or implantable cardioverter defibrillator (ICD). S...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Muhammad Asad, Qurban Hussain Khan, Azmat Hayat, Waheed -ur- Rehman, Muhammad Shabbir, Amer Naseem, Noor Shah, Rehana Khadim
Formato: article
Lenguaje:EN
Publicado: Army Medical College Rawalpindi 2020
Materias:
R
Acceso en línea:https://doaj.org/article/c11811ad31db4e029246ec63814c3fb1
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c11811ad31db4e029246ec63814c3fb1
record_format dspace
spelling oai:doaj.org-article:c11811ad31db4e029246ec63814c3fb12021-12-02T19:12:13ZTRICUSPID VALVE REGURGITATION IN PATIENTS UNDERGOING ENDOCARDIAL LEADS PLACEMENTdoi.org/10.51253/pafmj.v70iSuppl-4.60070030-96482411-8842https://doaj.org/article/c11811ad31db4e029246ec63814c3fb12020-12-01T00:00:00Zhttps://pafmj.org/index.php/PAFMJ/article/view/6007https://doaj.org/toc/0030-9648https://doaj.org/toc/2411-8842Objective: To assess prospectively the presence and degree of tricuspid regurgitation (TR) after right ventricular (RV) lead placement utilizing 2-dimensional and doppler echocardiography in a group of patients implanted with Permanent pace-maker or implantable cardioverter defibrillator (ICD). Study Design: Descriptive cross sectional study. Place and Duration of Study: Study was conducted at OPD of AFIC/NIHD Rawalpindi from Jan to Jun 2019. Methodology: One hundred patients after cardiac stimulation system implantation were included in this study. Patients with severe valve disease, heart failure, congenital heart disease, pre-existing pulmonary hypertension and presence of moderate or severe tricuspid regurgitation were excluded. M-mode, 2 –dimensional and doppler echocardiographic studies were performed. Continuous-wave doppler measurements were made from apical four-chamber view in order to obtain maximum tricuspid flow velocities. A complete echocardiographic study was performed following device implantation. Echocardiographic measurements were repeated at 6-months of follow-up period. Those patients who developed tricuspid regurgitation were further assessed by color doppler, taking into account density and contour of the jet on continuous-wave doppler. Tricuspid regurgitation severity was classified into three groups: mild, moderate and severe according to the recommendations for non-invasive evaluation of native valvular regurgitation by the American Society of Echocardiography. The collected data was analysed by using SPSS-23. Results: Out of 100 patients, 67 (67%) were males and 33(33%) were females with the mean age of 65.29 ± 12.02 years. All the patients had normal chambers dimensions before the procedure. 65 (65%) had leads screwed to RV apex while 35 (35%) had through RV septum. 83 (83%) patients received a dual chamber device, while 17 (17%) patients got single chamber (ventricular) device implanted. Following device implantation after 6 months mild TR was noted in 4 (4%), moderate TR in 4 (4%) and severe TR 2 (2%) in cases. Conclusion: Tricuspid incompetence following endocardial leads implantation is not rare and occurred in approximately 10% of our patients. This complication may be preventable, because it is likely due to the interference of the endocardial lead with the TV.Muhammad AsadQurban Hussain KhanAzmat HayatWaheed -ur- RehmanMuhammad ShabbirAmer NaseemNoor ShahRehana KhadimArmy Medical College Rawalpindiarticlepermanent pacemakertricuspid regurgitationimplantable cardioverter defibrillatorsMedicineRMedicine (General)R5-920ENPakistan Armed Forces Medical Journal, Vol 70, Iss 4, Pp 721-725 (2020)
institution DOAJ
collection DOAJ
language EN
topic permanent pacemaker
tricuspid regurgitation
implantable cardioverter defibrillators
Medicine
R
Medicine (General)
R5-920
spellingShingle permanent pacemaker
tricuspid regurgitation
implantable cardioverter defibrillators
Medicine
R
Medicine (General)
R5-920
Muhammad Asad
Qurban Hussain Khan
Azmat Hayat
Waheed -ur- Rehman
Muhammad Shabbir
Amer Naseem
Noor Shah
Rehana Khadim
TRICUSPID VALVE REGURGITATION IN PATIENTS UNDERGOING ENDOCARDIAL LEADS PLACEMENT
description Objective: To assess prospectively the presence and degree of tricuspid regurgitation (TR) after right ventricular (RV) lead placement utilizing 2-dimensional and doppler echocardiography in a group of patients implanted with Permanent pace-maker or implantable cardioverter defibrillator (ICD). Study Design: Descriptive cross sectional study. Place and Duration of Study: Study was conducted at OPD of AFIC/NIHD Rawalpindi from Jan to Jun 2019. Methodology: One hundred patients after cardiac stimulation system implantation were included in this study. Patients with severe valve disease, heart failure, congenital heart disease, pre-existing pulmonary hypertension and presence of moderate or severe tricuspid regurgitation were excluded. M-mode, 2 –dimensional and doppler echocardiographic studies were performed. Continuous-wave doppler measurements were made from apical four-chamber view in order to obtain maximum tricuspid flow velocities. A complete echocardiographic study was performed following device implantation. Echocardiographic measurements were repeated at 6-months of follow-up period. Those patients who developed tricuspid regurgitation were further assessed by color doppler, taking into account density and contour of the jet on continuous-wave doppler. Tricuspid regurgitation severity was classified into three groups: mild, moderate and severe according to the recommendations for non-invasive evaluation of native valvular regurgitation by the American Society of Echocardiography. The collected data was analysed by using SPSS-23. Results: Out of 100 patients, 67 (67%) were males and 33(33%) were females with the mean age of 65.29 ± 12.02 years. All the patients had normal chambers dimensions before the procedure. 65 (65%) had leads screwed to RV apex while 35 (35%) had through RV septum. 83 (83%) patients received a dual chamber device, while 17 (17%) patients got single chamber (ventricular) device implanted. Following device implantation after 6 months mild TR was noted in 4 (4%), moderate TR in 4 (4%) and severe TR 2 (2%) in cases. Conclusion: Tricuspid incompetence following endocardial leads implantation is not rare and occurred in approximately 10% of our patients. This complication may be preventable, because it is likely due to the interference of the endocardial lead with the TV.
format article
author Muhammad Asad
Qurban Hussain Khan
Azmat Hayat
Waheed -ur- Rehman
Muhammad Shabbir
Amer Naseem
Noor Shah
Rehana Khadim
author_facet Muhammad Asad
Qurban Hussain Khan
Azmat Hayat
Waheed -ur- Rehman
Muhammad Shabbir
Amer Naseem
Noor Shah
Rehana Khadim
author_sort Muhammad Asad
title TRICUSPID VALVE REGURGITATION IN PATIENTS UNDERGOING ENDOCARDIAL LEADS PLACEMENT
title_short TRICUSPID VALVE REGURGITATION IN PATIENTS UNDERGOING ENDOCARDIAL LEADS PLACEMENT
title_full TRICUSPID VALVE REGURGITATION IN PATIENTS UNDERGOING ENDOCARDIAL LEADS PLACEMENT
title_fullStr TRICUSPID VALVE REGURGITATION IN PATIENTS UNDERGOING ENDOCARDIAL LEADS PLACEMENT
title_full_unstemmed TRICUSPID VALVE REGURGITATION IN PATIENTS UNDERGOING ENDOCARDIAL LEADS PLACEMENT
title_sort tricuspid valve regurgitation in patients undergoing endocardial leads placement
publisher Army Medical College Rawalpindi
publishDate 2020
url https://doaj.org/article/c11811ad31db4e029246ec63814c3fb1
work_keys_str_mv AT muhammadasad tricuspidvalveregurgitationinpatientsundergoingendocardialleadsplacement
AT qurbanhussainkhan tricuspidvalveregurgitationinpatientsundergoingendocardialleadsplacement
AT azmathayat tricuspidvalveregurgitationinpatientsundergoingendocardialleadsplacement
AT waheedurrehman tricuspidvalveregurgitationinpatientsundergoingendocardialleadsplacement
AT muhammadshabbir tricuspidvalveregurgitationinpatientsundergoingendocardialleadsplacement
AT amernaseem tricuspidvalveregurgitationinpatientsundergoingendocardialleadsplacement
AT noorshah tricuspidvalveregurgitationinpatientsundergoingendocardialleadsplacement
AT rehanakhadim tricuspidvalveregurgitationinpatientsundergoingendocardialleadsplacement
_version_ 1718377061665472512